Ebola Vaccine Undergoes Testing Against Bundibugyo Virus
5 Articles
5 Articles
The Ebola virus is transmitted by direct contact with body fluids of infected people or animals and causes severe hemorrhagic fever, vomiting, diarrhoea and internal bleeding
WHO: DR Congo Ebola Vaccine Trial to Start Soon
World Health Organisation (WHO) experts announced Tuesday that the Democratic Republic of Congo will launch its first clinical trial of an Ebola vaccine by… The post WHO: DR Congo Ebola Vaccine Trial to Start Soon appeared first on Latest Breaking News - News Central TV.
Ebola Vaccine Undergoes Testing Against Bundibugyo Virus
Scientists are preparing to test vaccine candidates against the Bundibugyo virus in the Democratic Republic of the Congo (DRC). The Phase 2/3 clinical trial, expected to begin in the coming weeks subject to ethical and regulatory approval, will assess the safety and effectiveness of existing and experimental vaccines against the virus. The Coalition for Epidemic […] Ebola Vaccine Undergoes Testing Against Bundibugyo Virus is first published on T…
Number of deaths due to Ebola virus in RDCongo reached 4,381 and more than 9,000 cases were recorded.
The World Health Organization (WHO) has announced a specific clinical trial for vaccines against the Bundibugyo virus, responsible for the Ebola outbreak in the Democratic Republic of the Congo. The WHO Immunization Expert Group, SAGE, is developing a platform to test vaccines against this strain of the virus, including the existing vaccine for the Zaire strain.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
